LabCorp Acquires Pathology, Inc.
Washington, DC, March 21, 2016 – England Securities, LLC is pleased to announce that it served as the exclusive financial advisor to Pathology, Inc. in the sale of substantially all of its operating assets to Laboratory Corporation of America Holdings (LabCorp) (NYSE:LH). The acquisition includes Pathology, Inc.’s patient service centers used to conduct its medical testing and services businesses.
“Pathology, Inc. is a premier laboratory known for quality, science and innovation in women’s health testing,” said David P. King, chairman and chief executive officer of LabCorp. “It is an excellent fit with LabCorp’s existing women’s health service offerings and supports our mission to provide world class diagnostic solutions that improve health and improve lives.”
Pathology, Inc., a portfolio company of ABS Capital Partners, is the West Coast’s premier Women’s Health laboratory, with subspecialty expertise in anatomic, molecular and digital pathology. The company’s integrated diagnostic services help doctors personalize patient care to optimally treat disease and maintain health and wellness. Pathology, Inc. is a full-service laboratory offering both clinical and anatomic pathology testing, with nationally recognized pathology expertise in hematopathology, dermatopathology, cytopathology, genitourinary pathology, gynecology, and gastrointestinal pathology.
About England & Company
With offices in Houston, New York, and Washington, DC, England & Company is an independent investment banking and advisory boutique dedicated to serving middle-market companies. Since its founding in 2003, the firm has provided comprehensive advice on mergers and acquisitions, private capital raising, financial restructuring, fairness opinions, and other strategic initiatives to the executive teams, boards of directors, and financial sponsors of public and private companies.
Investment banking services are provided by England Securities LLC, a registered broker-dealer and member of FINRA and SIPC.